Think Bioscience utilizes living systems to program cells for the design and assembly of small-molecule therapeutics targeting difficult-to-address medical conditions. Their platform integrates applied microbiology, enzymology, and data science to enhance the efficiency of drug development processes.
Funding
$23.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many diseases are difficult to treat with existing drugs because the biological targets are hard to reach or modulate effectively with traditional synthetic chemistry approaches. Conventional drug discovery methods often struggle to identify small-molecule therapeutics that can selectively bind to these challenging targets and elicit the desired therapeutic effect.
Solution
Think Bioscience leverages synthetic biology to program living cells for the design and assembly of small-molecule therapeutics, enabling access to previously undruggable targets. Their platform integrates applied microbiology, enzymology, and data science to enhance the efficiency of drug development. By harnessing the capabilities of cellular chemical processors, Think Bioscience aims to create novel medicines that address difficult-to-treat medical conditions. This approach allows for the biosynthesis of complex molecules with improved target specificity and therapeutic potential.
Target Audience
Think Bioscience's primary customers are pharmaceutical companies and research institutions seeking innovative approaches to drug discovery and development, particularly for diseases with limited treatment options.
Features
- Cell-based platform for the biosynthesis of small-molecule therapeutics
- Integration of applied microbiology, enzymology, and data science
- Capability to target previously undruggable biological targets
- Enhanced efficiency in drug development processes
- Production of complex molecules with improved target specificity